EPZ015666 50 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
Search Results
Sulfatinib 5 mg | 98.93%
TargetMol
Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24 nM.
More Information Supplier PageSulfatinib
Reparixin 10 mg | 98.00%
TargetMol
Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
More Information Supplier PageReparixin
Reparixin 25 mg | 98.00%
TargetMol
Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
More Information Supplier PageReparixin
Reparixin 50 mg | 98.00%
TargetMol
Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
More Information Supplier PageReparixin
Reparixin 5 mg | 98.00%
TargetMol
Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
More Information Supplier PageReparixin
TCS-PIM-1-4a 10 mg | Purity Not Available
TargetMol
TCS-PIM-1-4a, a Pim inhibitor, blocks mTORC1 activity through activation of AMPK and kills a wide range of both myeloid and lymphoid cell lines (IC50=0.8-40 μM).
More Information Supplier PageTCS-PIM-1-4a
TCS-PIM-1-4a 50 mg | Purity Not Available
TargetMol
TCS-PIM-1-4a, a Pim inhibitor, blocks mTORC1 activity through activation of AMPK and kills a wide range of both myeloid and lymphoid cell lines (IC50=0.8-40 μM).
More Information Supplier PageTCS-PIM-1-4a
TCS-PIM-1-4a 5 mg | Purity Not Available
TargetMol
TCS-PIM-1-4a, a Pim inhibitor, blocks mTORC1 activity through activation of AMPK and kills a wide range of both myeloid and lymphoid cell lines (IC50=0.8-40 μM).
More Information Supplier PageTCS-PIM-1-4a
Diroximel fumarate 10 mg | Purity Not Available
TargetMol
Diroximel fumarate, a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body.
More Information Supplier PageDiroximel fumarate
